• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人激肽原与M蛋白相互作用,M蛋白是一种细菌表面蛋白和毒力决定因素。

Human kininogens interact with M protein, a bacterial surface protein and virulence determinant.

作者信息

Ben Nasr A B, Herwald H, Müller-Esterl W, Björck L

机构信息

Department of Medical and Physiological Chemistry, Lund University, Sweden.

出版信息

Biochem J. 1995 Jan 1;305 ( Pt 1)(Pt 1):173-80. doi: 10.1042/bj3050173.

DOI:10.1042/bj3050173
PMID:7826326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1136446/
Abstract

Streptococcus pyogenes, the most significant streptococcal species in clinical medicine, expresses surface proteins with affinity for several human plasma proteins. Here we report that kininogens, the precursors to the vasoactive kinins, bind to the surface of S. pyogenes. M protein, a surface molecule and a major virulence factor-in these bacteria, occurs in > 80 different serotypes. Among 49 strains of S. pyogenes, all of different M serotypes, 41 bound radiolabelled kininogens, whereas 6 M protein-negative mutant strains showed no affinity. M protein of most serotypes bind fibrinogen, and among the 55 strains tested, binding of kininogens was closely correlated to fibrinogen binding (r = 0.88, P < 0.0001). Western blotting, slot binding and enzyme immunoassay experiments demonstrated that M proteins isolated from S. pyogenes of three different M protein serotypes (M1, M6 and M46) bound kininogens. The affinity between kininogens and M1 protein was determined to be 5 x 10(7) M-1 and < or = 10(6) M-1 for high molecular weight (H-kininogen) and low molecular weight kininogen, respectively. The kininogen binding site was tentatively mapped to the N-terminal portion of M1 protein, and this site does not overlap the specific and separate binding sites for albumin, IgG and fibrinogen using monoclonal antibodies to, and synthetic peptides of, the kininogen sequence, the major M protein-binding site(s) was mapped to the C-terminal portion of the H-kininogen light chain. We anticipate that the kininogen-M protein interaction contributes to the host-parasite relationship in S. pyogenes infections.

摘要

化脓性链球菌是临床医学中最重要的链球菌种类,它表达的表面蛋白可与多种人类血浆蛋白结合。在此我们报告,血管活性激肽的前体激肽原可与化脓性链球菌的表面结合。M蛋白是这些细菌中的一种表面分子及主要毒力因子,存在80多种不同的血清型。在49株不同M血清型的化脓性链球菌菌株中,41株可结合放射性标记的激肽原,而6株M蛋白阴性突变菌株则无亲和力。大多数血清型的M蛋白可结合纤维蛋白原,在所检测的55株菌株中,激肽原的结合与纤维蛋白原的结合密切相关(r = 0.88,P < 0.0001)。蛋白质印迹法、狭缝印迹法和酶免疫测定实验表明,从三种不同M蛋白血清型(M1、M6和M46)的化脓性链球菌中分离出的M蛋白可结合激肽原。激肽原与M1蛋白之间的亲和力经测定分别为5×10⁷ M⁻¹(针对高分子量激肽原)和≤10⁶ M⁻¹(针对低分子量激肽原)。激肽原结合位点初步定位于M1蛋白的N端部分,且该位点不与白蛋白、IgG和纤维蛋白原的特异性及独立结合位点重叠。利用针对激肽原序列的单克隆抗体及合成肽,主要M蛋白结合位点定位于高分子量激肽原轻链的C端部分。我们预计激肽原与M蛋白的相互作用有助于化脓性链球菌感染中的宿主 - 病原体关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78c/1136446/773273927801/biochemj00072-0179-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78c/1136446/7adc15e1fa7e/biochemj00072-0177-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78c/1136446/b5629f2760f3/biochemj00072-0178-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78c/1136446/a18ff2ddf748/biochemj00072-0178-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78c/1136446/773273927801/biochemj00072-0179-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78c/1136446/7adc15e1fa7e/biochemj00072-0177-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78c/1136446/b5629f2760f3/biochemj00072-0178-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78c/1136446/a18ff2ddf748/biochemj00072-0178-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e78c/1136446/773273927801/biochemj00072-0179-a.jpg

相似文献

1
Human kininogens interact with M protein, a bacterial surface protein and virulence determinant.人激肽原与M蛋白相互作用,M蛋白是一种细菌表面蛋白和毒力决定因素。
Biochem J. 1995 Jan 1;305 ( Pt 1)(Pt 1):173-80. doi: 10.1042/bj3050173.
2
M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes.M1蛋白和H蛋白:由相邻基因编码的结合IgGFc和白蛋白的链球菌表面蛋白。
Biochem J. 1994 Jun 15;300 ( Pt 3)(Pt 3):877-86. doi: 10.1042/bj3000877.
3
Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin.化脓性链球菌从人血浆中吸收激肽原后会释放缓激肽。
Biochem J. 1997 Sep 15;326 ( Pt 3)(Pt 3):657-60.
4
Assessment of the interaction of human complement regulatory proteins with group A Streptococcus. Identification of a high-affinity group A Streptococcus binding site in FHL-1.人类补体调节蛋白与A群链球菌相互作用的评估。FHL-1中高亲和力A群链球菌结合位点的鉴定。
Eur J Immunol. 2000 Apr;30(4):1243-53. doi: 10.1002/(SICI)1521-4141(200004)30:4<1243::AID-IMMU1243>3.0.CO;2-D.
5
Susceptibility of chicken embryos to group A streptococci: correlation with fibrinogen binding.鸡胚对A组链球菌的易感性:与纤维蛋白原结合的相关性。
FEMS Immunol Med Microbiol. 1993 Oct;7(3):231-40. doi: 10.1111/j.1574-695X.1993.tb00403.x.
6
A secreted receptor related to M1 protein of Streptococcus pyogenes binds to fibrinogen, IgG, and albumin.一种与化脓性链球菌M1蛋白相关的分泌型受体可与纤维蛋白原、IgG和白蛋白结合。
Zentralbl Bakteriol. 1990 Jun;273(2):216-28. doi: 10.1016/s0934-8840(11)80252-5.
7
Direct Host Plasminogen Binding to Bacterial Surface M-protein in Pattern D Strains of Streptococcus pyogenes Is Required for Activation by Its Natural Coinherited SK2b Protein.化脓性链球菌D型菌株中,宿主纤溶酶原直接结合至细菌表面M蛋白是由其天然共遗传的SK2b蛋白激活所必需的。
J Biol Chem. 2015 Jul 24;290(30):18833-42. doi: 10.1074/jbc.M115.655365. Epub 2015 Jun 12.
8
Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system.化脓性链球菌的免疫球蛋白结合表面蛋白也能结合人C4b结合蛋白(C4BP),后者是补体系统的一种调节成分。
J Immunol. 1995 Jan 1;154(1):375-86.
9
Analysis of plasminogen-binding M proteins of Streptococcus pyogenes.化脓性链球菌纤溶酶原结合M蛋白的分析
Methods. 2000 Jun;21(2):143-50. doi: 10.1006/meth.2000.0985.
10
Mapping of binding sites for human serum albumin and fibrinogen on the M3-protein. Molecular model and function in the pathogenic mechanism.人血清白蛋白和纤维蛋白原在M3蛋白上结合位点的定位。分子模型及其在致病机制中的作用。
Adv Exp Med Biol. 1997;418:577-9. doi: 10.1007/978-1-4899-1825-3_133.

引用本文的文献

1
An antibody targeting high-molecular-weight kininogen blocks contact system activation in a model of polymicrobial sepsis.一种靶向高分子量激肽原的抗体可在多微生物败血症模型中阻断接触系统激活。
J Thromb Haemost. 2025 Aug 8. doi: 10.1016/j.jtha.2025.07.032.
2
Salivary Chemical Barrier Proteins in Oral Squamous Cell Carcinoma-Alterations in the Defense Mechanism of the Oral Cavity.口腔鳞状细胞癌中的唾液化学屏障蛋白——口腔防御机制的改变。
Int J Mol Sci. 2023 Sep 4;24(17):13657. doi: 10.3390/ijms241713657.
3
Chemical Barrier Proteins in Human Body Fluids.

本文引用的文献

1
Current knowledge of type-specific M antigens of group A streptococci.A组链球菌特定类型M抗原的现有知识。
J Immunol. 1962 Sep;89:307-13.
2
STREPTOCOCCAL PROTEINASE: THE ZYMOGEN TO ENZYME TRANSFROMATION.链球菌蛋白酶:酶原向酶的转化
J Biol Chem. 1965 Mar;240:1138-42.
3
FIBRINOGEN PRECIPITATION BY STREPTOCOCCAL M PROTEIN. I. IDENTITY OF THE REACTANTS, AND STOICHIOMETRY OF THE REACTION.链球菌M蛋白引起的纤维蛋白原沉淀。I. 反应物的鉴定及反应的化学计量关系
人体体液中的化学屏障蛋白。
Biomedicines. 2022 Jun 22;10(7):1472. doi: 10.3390/biomedicines10071472.
4
Host Pathways of Hemostasis that Regulate Group A Streptococcus pyogenes Pathogenicity.宿主止血途径调控 A 组链球菌致病性。
Curr Drug Targets. 2020;21(2):193-201. doi: 10.2174/1389450120666190926152914.
5
Kallikrein Cleaves C3 and Activates Complement.激肽释放酶裂解 C3 并激活补体。
J Innate Immun. 2018;10(2):94-105. doi: 10.1159/000484257. Epub 2017 Dec 14.
6
Streptococcus pyogenes triggers activation of the human contact system by streptokinase.化脓性链球菌通过链激酶触发人类接触系统的激活。
Infect Immun. 2015 Aug;83(8):3035-42. doi: 10.1128/IAI.00180-15.
7
The role of coagulation/fibrinolysis during Streptococcus pyogenes infection.化脓性链球菌感染期间凝血/纤维蛋白溶解的作用。
Front Cell Infect Microbiol. 2014 Sep 11;4:128. doi: 10.3389/fcimb.2014.00128. eCollection 2014.
8
Disease manifestations and pathogenic mechanisms of Group A Streptococcus.A 组链球菌的疾病表现及致病机制
Clin Microbiol Rev. 2014 Apr;27(2):264-301. doi: 10.1128/CMR.00101-13.
9
A novel role for pro-coagulant microvesicles in the early host defense against streptococcus pyogenes.促凝微囊在早期宿主防御化脓性链球菌中的新作用。
PLoS Pathog. 2013;9(8):e1003529. doi: 10.1371/journal.ppat.1003529. Epub 2013 Aug 1.
10
Calorimetric analysis of the plasma proteome: identification of type 1 diabetes patients with early renal function decline.血浆蛋白质组的量热分析:早期肾功能下降的1型糖尿病患者的识别。
Biochim Biophys Acta. 2013 Oct;1830(10):4675-80. doi: 10.1016/j.bbagen.2013.05.007. Epub 2013 May 10.
J Exp Med. 1965 May 1;121(5):849-59. doi: 10.1084/jem.121.5.849.
4
Contiguous binding and inhibitory sites on kininogens required for the inhibition of platelet calpain.抑制血小板钙蛋白酶所需的激肽原上的相邻结合位点和抑制位点。
J Biol Chem. 1993 Dec 15;268(35):26546-51.
5
PAM, a novel plasminogen-binding protein from Streptococcus pyogenes.PAM,一种来自化脓性链球菌的新型纤溶酶原结合蛋白。
J Biol Chem. 1993 Dec 5;268(34):25417-24.
6
M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes.M1蛋白和H蛋白:由相邻基因编码的结合IgGFc和白蛋白的链球菌表面蛋白。
Biochem J. 1994 Jun 15;300 ( Pt 3)(Pt 3):877-86. doi: 10.1042/bj3000877.
7
Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes.化脓性链球菌中一种保守的细胞外半胱氨酸蛋白酶将白细胞介素1β(IL-1β)前体切割以产生活性IL-1β。
Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7676-80. doi: 10.1073/pnas.90.16.7676.
8
Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.前激肽释放酶高分子量激肽原结合位点的定位。前激肽释放酶重链不同片段形成不连续表位的证据。
J Biol Chem. 1993 Jul 5;268(19):14527-35.
9
Structural dissection of the multidomain kininogens. Fine mapping of the target epitopes of antibodies interfering with their functional properties.多结构域激肽原的结构剖析。干扰其功能特性的抗体靶表位的精细定位。
J Biol Chem. 1993 Apr 25;268(12):9079-91.
10
Effect of specific binding of human albumin, fibrinogen, and immunoglobulin G on surface characteristics of bacterial strains as revealed by partition experiments in polymer phase systems.通过聚合物相系统中的分配实验揭示人白蛋白、纤维蛋白原和免疫球蛋白G的特异性结合对细菌菌株表面特性的影响。
Infect Immun. 1980 Sep;29(3):879-85. doi: 10.1128/iai.29.3.879-885.1980.